We found a significant reduction of overall jet lag symptoms ( VAS ) , subjective sleepiness ( KSS ) , and the fatigue , inertia , and forgetfulness subscales of the POMS when comparing the active TBL treatment group ( N = 30 ) to the placebo group ( N = 25 ) .